Loading...
Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population
Multiple studies have demonstrated that obesity is associated with a worse outcome for all breast cancer subtypes and that obese breast cancer patients do not respond as well as normal weight patients to aromatase inhibitor treatment and chemotherapy. While a number of mechanisms have been proposed...
Na minha lista:
| Udgivet i: | Curr Pharmacol Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591549/ https://ncbi.nlm.nih.gov/pubmed/26442202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-015-0041-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|